Search Results - "Baghian, Ali"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts by Sartor, Oliver, Baghian, Ali

    Published in Frontiers in medicine (06-12-2022)
    “…Prostate specific membrane antigen (PSMA) represents a validated target for prostate cancer therapeutics. The phase III VISION study with lutetium (…”
    Get full text
    Journal Article
  2. 2

    Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases by Xie, John, Jang, Albert, Vegel, Andrew, Hajja, Yasmin, Mouawad, Yara, Baghian, Ali, Berbari, Bachir, Schmid, Janet L., Socola, Francisco, Safah, Hana, Saba, Nakhle S.

    Published in Leukemia research reports (01-01-2021)
    “…“Accelerated” chronic lymphocytic leukemia/small lymphocytic lymphoma (A-CLL) is a rare histological variant of CLL/SLL, which tends to exhibit an aggressive…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Long-Term Outcomes of Autologous Hematopoietic Cell Transplantation Using Melphalan and Total Body Irradiation Conditioning in Multiple Myeloma by Baghian, Ali, Munker, Reinhold, Koleva, Yordanka, Matharoo, Gunita, Andrews, Patricia, Wright, Ato, Saba, Nakhle S., Safah, Hana

    Published in Blood (02-12-2016)
    “…Background: The prognosis of multiple myeloma (MM) has improved significantly over the last 20 years due to the introduction of autologous stem cell…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Targeting MALT1 with the Small Molecule Inhibitor MI2 Induces a Caspase-Dependent Apoptosis and Inhibits the NF-κb Pathway in Chronic Lymphocytic Leukemia Primary Cells by Tanios, Georges, Lobelle-Rich, Patricia, Vasudevamurthy, Ashwin, Atkinson, Thomas S., Baghian, Ali, Liu, Delong, Safah, Hana, Flemington, Erik K., Saba, Nakhle S.

    Published in Blood (02-12-2016)
    “…Targeting the B-cell receptor (BCR) pathway in chronic lymphocytic leukemia (CLL) with the Bruton Tyrosine Kinase (BTK) inhibitor Ibrutinib has transformed the…”
    Get full text
    Journal Article
  7. 7

    Long‐term follow‐up of patients with multiple myeloma treated with total body irradiation—Melphalan conditioning by Munker, Reinhold, Baghian, Ali, Koleva, Yordanka, Andrews, Patricia, Matharoo, Gunita S., Wright, Ato E., Saba, Nakhle S., Weiner, Roy S., Safah, Hana

    Published in European journal of haematology (01-07-2017)
    “…Background and Objectives Since a study published in 2002 showed a survival advantage of melphalan‐only conditioning for stem cell transplantation (HSCT) over…”
    Get full text
    Journal Article
  8. 8